Zentalis Pharmaceuticals (ZNTL) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $160000.0.
- Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization fell 5015.58% to $160000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $160000.0, marking a year-over-year decrease of 5015.58%. This contributed to the annual value of $1.3 million for FY2024, which is 714.29% down from last year.
- According to the latest figures from Q3 2025, Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization is $160000.0, which was down 5015.58% from $160000.0 recorded in Q2 2025.
- Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $1.4 million during Q4 2022, with a 5-year trough of $160000.0 in Q2 2025.
- Moreover, its 4-year median value for Accumulated Depreciation & Amortization was $344000.0 (2022), whereas its average is $519933.3.
- In the last 5 years, Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization skyrocketed by 465.12% in 2023 and then tumbled by 5107.03% in 2025.
- Quarter analysis of 4 years shows Zentalis Pharmaceuticals' Accumulated Depreciation & Amortization stood at $1.4 million in 2022, then fell by 1.82% to $1.4 million in 2023, then dropped by 7.14% to $1.3 million in 2024, then tumbled by 87.69% to $160000.0 in 2025.
- Its last three reported values are $160000.0 in Q3 2025, $160000.0 for Q2 2025, and $262000.0 during Q1 2025.